Menstrual issues in adolescents with physical and developmental disabilities

Annals of the New York Academy of Sciences

Volumn 1135, Issue , 2008, Pages 230-236

  Quint, Elisabeth H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adolescents; Developmental disabilities; Menstrual hygiene; Menstruation; Physical disabilities

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM; DROSPIRENONE; ESTROGEN; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; VITAMIN D;

AMENORRHEA; ANOVULATION; BEHAVIOR CHANGE; BIRTH CONTROL; BONE DENSITY; BREAKTHROUGH BLEEDING; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DEVELOPMENTAL DISORDER; DRUG EFFICACY; DYSMENORRHEA; ENDOMETRIUM ABLATION; ESTROGEN BLOOD LEVEL; FEMININE HYGIENE PRODUCT; FRACTURE; GESTAGEN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INCREASED APPETITE; LUNG EMBOLISM; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION; MENSTRUATION DISORDER; MOOD DISORDER; ORAL CONTRACEPTION; OSTEOPOROSIS; PAIN THRESHOLD; PHYSICAL DISABILITY; RECOMMENDED DRUG DOSE; REPRODUCTIVE HEALTH; SEXUAL ABUSE; SEXUAL BEHAVIOR; SEXUAL EDUCATION; SEXUALITY; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 45549097157     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1429.020     Document Type: Conference Paper

References (49)

1. Kaplowitz, P. 2006. Pubertal development in girls: secular trends. Curr. Opinion Obstet. Gynecol. 18 : 487 491.
2. McDowell, M.A., D.J. Brody & J.P. Hughes. 2007. Has age at menarche changed? Results from the National Health and Nutrition Examination Survey (NHANES) 1999-2004. J. Adolesc. Health 40 : 227 231.
3. Knickmeyer, R.C., S. Wheelwright, R. Hoekstra & S. Baron-Cohen. 2006. Age of menarche in females with autism spectrum conditions. Devel. Med. Child Neurol. 48 : 1007 1008.
4. Worley, G., C.M. Houlihan, M.E. Herman-Giddens, et al. 2002. Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey. Pediatrics 110 : 897 902.
5. Cento, R.M., M. Ciampelli, C. Proto, et al. 2001. Neuroendocrine features of pubertal development in females with mental retardation. Gynecol. Endocrinol. 15 : 178 183.
6. Cento, R.M., L. Ragusa, C. Proto, et al. 1996. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome. Gynecol. Endocrinol. 10 : 133 137.
7. Scola, P.S. & S.M. Pueschel. 1992. Menstrual cycles and basal body temperature curves in women with Down syndrome. Obstet. Gynecol. 79 : 91 94.
8. Bauer, J., J.L. Isojarvi, A.G. Herzog, et al. 2002. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and treatment. J. Neurol. Neurosurg. Psych. 73 : 121 125.
9. Bilo, L., R. Meo, C. Nappi, et al. 1988. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 29 : 612 619.
10. Herzog, A.G. & S.C. Schachter. 2001. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 42 : 311 315.
11. Isojarvi, J.I.T., T.J. Latikainen, A.J. Pakarinen, et al. 1993. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N. Engl. J. Med. 329 : 1383 1388.
12. Wieck, A. & P.M. Haddad. 2003. Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: selective literature review. Br. J. Psych. 182 : 199 204.
13. Cohen, W.I. 2006. Current dilemmas in Down syndrome clinical care: celiac disease, thyroid disorders, and atlanto-axial instability. Am. J. Med. Genet. Semin. Med. Genet. 142 : 141 148.
14. Dizon, C.D., L.M. Allen & M.P. Ornstein. 2005. Menstrual and contraceptive issues among young women with developmental disability: a retrospective review of cases of the Hospital for Sick Children, Toronto. J. Ped. Adolescent. Gynecol. 18 : 157 162.
15. Csermely, T., L. Halvax, M. Vizer et al. 2007. Relationship between adolescent amenorrhea and climacteric osteoporosis. Maturitas 56 : 368 374.
16. Murphy, N.A. & E.R. Elias. 2006. Sexuality of children and adolescents with developmental disabilities. Pediatrics 118 : 398 403.
17. Quint, E.H., T.E. Elkins, C.A. Sorg & S. Kope. 1999. The treatment of cyclical behavioral changes in women with mental disabilities. J. Ped. Adolesc. Gynecol. 12 : 139 142.
18. American College of Obstetrics and Gynecology. 2000. ACOG practice Bulletin: Premenstrual Syndrome. Washington, DC.
19. Davis, A.R. & C.L. Westhoff. 2001. Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives. J. Ped. Adolesc. Gynecol. 14 : 3 8.
20. Borges, L.E., R.P. Andrade, J.M. Aldrighi, et al. 2006. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception. Contraception 74 : 446 450.
21. Wyatt, K.M., P.W. Dimmock & P.M O'Brien. 2005. Selective serotonin reuptake inhibitors for premenstrual syndrome. In The Cochrane Database of Systematic Reviews (3) Art. No: CD001396.
22. Gray, S.H. & S.J. Emans. 2007. Abnormal vaginal bleeding in adolescents. Ped. Rev. 28 : 175 182.
23. Albanese, A. & N.W. Hopper. 2007. Suppression of menstruation in adolescents with severe learning disabilities. Arch. Dis. Child. 92 : 629 32.
24. Bonnar, J. & B.L. Sheppard. 1996. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 313 : 579 582.
25. Edelman, A.B., M.F. Gallo, J.T. Jensen, et al. 2005. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. In Cochrane Database Syst. Rev. CD004695.
26. Sucato, G.S. & K.L. Gerschultz. 2005. Extended cycle hormonal contraception in adolescents. Curr. Opin. Obstet. Gynecol. 17 : 461 465.
27. Rousseau, M.C. & B. Guillotel. 2001. Risk factors for deep venous thrombosis in tetraparesic mentally retarded patients. Brain Injury 15 : 1041 1044.
28. Lohiya, G.S., F.M. Crinella, L. Tan-Figueroa & S. Go. 2005. Deep vein thrombosis in a tetraparesic patient with mental retardation: case report and review of the literature. Brain Injury 19 : 739 742.
29. Schreijer, A.J., S.C. Cannegieter, J.C. Meijers, et al. 2006. Activation of coagulation system during air travel: a crossover study. Lancet 367 : 832 838.
30. Tanis, B.C. & F.R. Rosendaal. 2003. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Semin. Vasc. Med. 3 : 69 84.
31. Savelli, S.L., B.A. Kerlin, M.A. Springer, et al. 2006. Recommendations for screening for thrombophilic tendencies in teenage females prior to contraceptive initiation. J. Ped. Adolesc. Gynecol. 19 : 313 316.
32. Cole, J.A., H. Norman, M. Doherty, et al. 2007. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet. Gynecol. 109 : 339 346.
33. DiVasta, A.D. & C.M. Gordon. 2006. Bone health in adolescents. Adolesc. Med. Clin. 17 : 639 652.
34. Understanding the needs of women with epilepsy or risk OC failure. 1998. In Contraceptive Technol. Update 19 : 109 1011.
35. Arias, R.D., J.K. Jain, C. Brucker, et al. 2006. Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. Contraception 74 : 234 238.
36. Westhoff, C., J.K. Jain, I. Milsom, et al. 2007. Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 75 : 261 267.
37. Bonny, A., K. Camlin, R. Harvey, et al. 2003. Prospective analysis of weight changes in adolescent females initiating depot medroxyprogesterone acetate (DMPA), oral contraceptive pills, or no hormonal method. J. Adolesc. Health 32 : 134.
38. Cromer, B.A., M. Stager, A. Bonny et al. 2004. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J. Adolesc. Health 35 : 434 441.
39. Lopez, L.M., D.A. Grimes, K.F. Schulz, et al. 2006. Steroidal contraceptives: effect on bone fractures in women. In Cochrane Database of Systematic Reviews. (4):CD006033.
40. King, W., R. Levin, R. Schmidt, et al. 2003. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev. Med. Child. Neurol. 45 : 12 16.
41. Henderson, R.C., R.K. Lark, M.J. Gurka, et al. 2002. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110 : 1 10.
42. Watson, K.C., M.J. Lentz & K.C. Cain. 2006. Associations between fracture incidence and use of depot medroxyprogesterone acetate and anti-epileptic drugs in women with developmental disabilities. Womens' Health Issues 16 : 346 352.
43. Schrager, S., C. Kloss & A.W. Ju. 2007. Prevalence of fractures in women with intellectual disabilities: a chart review. J. Intellect. Disabil. Res. 51 : 253 259.
44. Pluskiewicz, W., B. Drozdzowska, A. Lyssek-Boro, et al. 2006. Densitometric and quantitative ultrasound measurements and laboratory investigations in wheelchair-bound patients. J. Clin. Densitom. 9 : 78 83.
45. Funk, S., M.M. Miller, D.R. Mishell, Jr., et al. 2005. The Implanon US Study Group. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71 : 319 326.
46. Hidalgo, M., L. Bahamondes, M. Perrotti, et al. 2002. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 65 : 129 132.
47. Suhonen, S., M. Haukkamaa, T. Jakobsson & I. Rauramo. 2004. Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 69 : 407 412.
48. Paransky, O.I. & R.K. Zurawin. 2003. Management of menstrual problems and contraception in adolescents with mental retardation: a medical, legal, and ethical review with new suggested guidelines. J. Pediat. Adolesc. Gynecol. 16 : 223 235.
49. American College of Obstetrics and Gynecology. 1999. Sterilization of women, including those with mental disabilities. In ACOG Committee Opinion 216. Washington, DC.